Stay updated on ASCT With Nivolumab in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the ASCT With Nivolumab in Multiple Myeloma Clinical Trial page.

Latest updates to the ASCT With Nivolumab in Multiple Myeloma Clinical Trial page
- Check2 days agoChange DetectedAdded related topics sections for 'Multiple myeloma' and 'MedlinePlus Genetics' on the Study Details page.SummaryDifference0.2%

- Check10 days agoChange DetectedRemoved MedlinePlus Genetics topic on multiple myeloma; genetics content on that disease is no longer shown on the page.SummaryDifference0.3%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedUpdate to v3.2.0 with an added MedlinePlus Genetics topic (Multiple myeloma) and a government operating status notice; old v3.1.0 was removed.SummaryDifference5%

- Check31 days agoChange DetectedTerminology updated from 'Plasma cell myeloma' to 'Multiple myeloma' and version bumped from v3.0.2 to v3.1.0.SummaryDifference0.3%

- Check38 days agoChange Detected- Removed MedlinePlus Genetics topic on multiple myeloma. - This reduces the page's coverage of a genetics-related disease topic.SummaryDifference0.4%

- Check46 days agoChange DetectedAdded a MedlinePlus Genetics topic for Multiple myeloma, expanding core content. The page revision was bumped from v3.0.1 to v3.0.2, and the 'Back to Top' link was removed as a minor UI cleanup.SummaryDifference0.7%

Stay in the know with updates to ASCT With Nivolumab in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ASCT With Nivolumab in Multiple Myeloma Clinical Trial page.